Critical review and recommendations for nesiritide use in the emergency department

Journal of Emergency Medicine

Volumn 29, Issue 3, 2005, Pages 317-329

  Collins, Sean P ^a   Hinckley, William R ^a   Storrow, Alan B ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Emergency department; Heart failure; Nesiritide

Indexed keywords

AMRINONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HYDRALAZINE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; MILRINONE; NESIRITIDE; NITRATE; NITROPRUSSIDE SODIUM; POTASSIUM; SPIRONOLACTONE; VASOACTIVE AGENT; VASODILATOR AGENT;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ANGINA PECTORIS; ARTERY CATHETERIZATION; BRADYCARDIA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; DRUG APPROVAL; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG HALF LIFE; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DRUG SAFETY; DYSPNEA; EMERGENCY WARD; FATIGUE; HEADACHE; HEALTH CARE COST; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE ARRHYTHMIA; HOSPITALIZATION; HUMAN; HYPOTENSION; INCIDENCE; KIDNEY FAILURE; LOW DRUG DOSE; MEDICARE; MORTALITY; NONHUMAN; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT OUTCOME;

EID: 25644440072     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jemermed.2005.01.028     Document Type: Article

References (38)

1. J.D. Sackner-Bernstein, H.A. Skopicki, K.D. Aaronson Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure Circulation 111 12 2005 1487 1491
2. J.D. Sackner-Bernstein, M. Kowalski, M. Fox, K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure a pooled analysis of randomized controlled trials Jama 293 15 2005 1900 1905
3. B. Kisch Electron microscopy of the atrium of the heart Exp Med Surg 14 1956 99 112
4. J.P. Henry, J.W. Pearce The possible role of cardiac stretch receptors in the induction of changes in urine flow J Physiol 131 1956 572 594
5. A.S. Maisel, P. Krishnaswamy, R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
6. Scios Inc. Package insert for nesiritide.
7. W.S. Colucci, U. Elkayam, D.P. Horton Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group N Engl J Med 343 2000 246 253
8. National Heart, Lung, and Blood Institute Morbidity and mortality 2002 chart book on cardiovascular, lung, and blood diseases 2002 National Institutes of Health Bethesda, MD
9. A.J. Burger, D.P. Horton, T. LeJemtel Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure the PRECEDENT study Am Heart J 144 2002 1102 1108
10. R.M. Mills, T.H. LeJemtel, D.P. Horton Natrecor Study Group Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure a randomized, double-blind, placebo-controlled clinical trial J Am Coll Cardiol 34 1999 155 162
11. J. Sackner-Bernstein, M. Kowalski Is there risk associated with the use of nesiritide for acute heart failure J Am Coll Cardiol 41 Suppl 1 2003 161
12. E. Abraham, K. Adams, G. Fonarow, Comparison of in-hospital mortality in patients treated with nesiritide vs. other pareneral vasoactive medications for acutely decompensated heart failure an analysis from a large prospective registry database J Card Fail 9 Suppl 5 2003 S81
13. G. Mulki, C. Pisano, C. Gallagher Safety and efficacy of intermittent, short-term, outpatient nesiritide infusions for the treatment of decompensated heart failure J Card Fail 9 Suppl 5 2003 S68
14. W. Beck, O. Bruton, K. Christensen Is outpatient nesiritide safe for hypotensive heart failure patients? J Card Fail 9 Suppl 5 2003 S98
15. A. Bhaskaran, R. Siegel, B. Barker Safety and efficacy of nesiritide use in an out-patient heart failure program initial results J Card Fail 9 Suppl 5 2003 S98
16. C. Yancy, M. Saltzberg, R. Berkowitz Management of patients with congestive heart failure after hospitalization results from the Follow Up Serial Infusions of Nesiritide (FUSION) Trial J Card Fail 9 Suppl 5 2003 S11
17. W.F. Peacock, C.L. Emerman, J. Young PROACTION study group Safety and efficacy of nesiritide in the treatment of decompensated heart failure in observation patients J Am Coll Cardiol 4 6 Suppl 2003 336A
18. C. Hunter, D. Hilleman, M. Malesker Cost-effectiveness of nesiritide in acute decompensated heart failure J Card Fail 8 2002 S1
19. T. Lenz, P. Foral, M. Malesker Impact of nesiritide on complications and health-care resources in decompensated heart failure J Card Fail 9 Suppl 5 2003 S66
20. Publication Committee for the VMAC Investigators Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure a randomized controlled trial (Vasodilatation in the Management of Acute CHF) JAMA 287 2002 1531 1540
21. J. Butler, C. Emerman, W.F. Peacock The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure Nephrol Dial Transplant 19 2004 391 399
22. W.F. Peacock, C.L. Emerman, J. Young Nesiritide in congestive heart failure associated with acute coronary syndromes a pilot study of safety and efficacy J Card Fail 10 2004 120 125
23. U. Elkayam, M.W. Akhter, H. Singh Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerin in patients with decompensated heart failure Am J Cardiol 93 2004 237 240
24. M.A. Silver, D.P. Horton, J.K. Ghali Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure J Am Coll Cardiol 39 2002 798 803
25. A. Elis, T. Bental, O. Kimchi Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure a randomized, double-blind, placebo-controlled study Clin Pharmacol Ther 63 1998 682 685
26. F. Dies, M. Krell, P. Whitlow Intermittent dobutamine in ambulatory outpatients with chronic cardiac failure Circulation 74 Suppl II 1986 II-138
27. Karkaowsky AA. NDA 20-920. Available at: http://www.fda.gov/cder/foi/nda/ 2001/20-920_natrecor_medr_p3.pdf, 2001. Accessed January 25, 2004.
28. A.J. Cowley, D.J. McEntegart, J.R. Hampton Long-term evaluation of treatment for chronic heart failure a 1 year comparative trial of flosequinan and captopril Cardiovasc Drugs Ther 8 1994 829 836
29. T.B. Conradson, L. Ryden, G. Ahlmark Clinical efficacy of hydralazine in chronic heart failure one-year double-blind placebo-controlled study Am Heart J 108 1984 1001 1006
30. J.A. Franciosa, S.R. Goldsmith, J.N. Cohn Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure Am J Med 69 1980 559 566
31. J.N. Cohn, G. Johnson, S. Ziesche A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure N Engl J Med 325 1991 303 310
32. J.N. Cohn, D.G. Archibald, S. Ziesche Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study N Engl J Med 314 1986 1547 1552
33. C. Emerman, W.F. Peacock, G.C. Fonarow Effect of emergency department initiation of vasoactive infusion therapy on heart failure length of stay Ann Emerg Med 40 2002 S46
34. W.F. Peacock, J. Allegra, D. Ander Management of acute decompensated heart failure in the emergency department Congest Heart Fail 9 Suppl 1 2003 3 18
35. J.B. O'Connell, M.R. Bristow Economic impact of heart failure in the United States time for a different approach J Heart Lung Transplant 13 1994 S107 S112
36. W.F. Peacock Rapid optimization strategies for optimal care of decompensated congestive heart-failure patients in the emergency department Rev Cardiovasc Med 3 Suppl 4 2002 S41 S48
37. G. de Lissovoy, D.M. Stier, G. Ciesla Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure Am J Cardiol 92 2003 631 633
38. J.E. Rame, M.A. Sheffield, D.L. Dries Outcomes after emergency department discharge with a primary diagnosis of heart failure Am Heart J 142 2001 714 719